• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于经动脉化疗栓塞术治疗的肝细胞癌患者疲劳和功能状态的综合出院计划项目:一项随机临床对照试验。

A comprehensive discharge planning program on fatigue and functional status of patients with hepatocellular carcinoma undergoing transarterial chemoembolization: A randomized clinical controlled trial.

作者信息

Yenjai Nawiya, Asdornwised Usavadee, Wongkongkam Kessiri, Pinjaroen Nutcha

机构信息

Master of Nursing Science Program in Adult and Gerontological Nursing, Faculty of Nursing, Mahidol University, Bangkok, Thailand.

Faculty of Nursing, Mahidol University, Bangkok, Thailand.

出版信息

Belitung Nurs J. 2022 Aug 18;8(4):287-295. doi: 10.33546/bnj.2140. eCollection 2022.

DOI:10.33546/bnj.2140
PMID:37546491
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10401379/
Abstract

BACKGROUND

Post transarterial chemoembolization (post-TACE) causes side effects that impact patients, which leads to fatigue symptoms and reduced functional status. However, unrelieved fatigue and reduced functional status may cause patients to withdraw from treatment and negatively affect their lives. Unfortunately, the patients post-TACE only receive routine medical care at the hospital but no follow-up and continuity of care back home. Therefore, comprehensive discharge planning for these problems is necessary.

OBJECTIVE

This study examined the effectiveness of the comprehensive discharge planning program on fatigue and functional status of patients with hepatocellular carcinoma undergoing transarterial chemoembolization.

METHODS

A randomized clinical controlled trial was used. Fifty-two patients who met the study criteria were randomly assigned to an experimental group ( = 26) receiving the comprehensive discharge planning plus routine care and a control group ( = 26) receiving routine care only. The discharge planning program was developed based on the Transitional Care Model. A demographic and health data questionnaire, Fatigue Severity Scale (FSS), and Enforced Social Dependency Scale (ESDS) were used for data collection. Chi-square, Fisher's exact, Wilcoxon signed-rank, and Mann-Whitney U tests were used for data analysis.

RESULTS

The mean scores for fatigue at 30 days after treatment between the experimental and control groups were significantly different ( = 0.003). The mean scores for the fatigue symptoms in the experimental and control groups were 1.27 ± 0.58 and 1.77 ± 0.85, respectively. The functional status from Day 7 to Day 14 after transarterial chemoembolization was different ( = 0.020). In addition, the mean scores for functional status between the experimental and control groups were significantly different ( = 0.020). On Day 14, after transarterial chemoembolization, the experimental group had an increased score in functional status from Day 7 over the scores for those in the control group.

CONCLUSION

The comprehensive discharge planning program effectively reduces fatigue symptoms and enhances the functional status in patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Therefore, the comprehensive discharge planning program can be used by nurses and multidisciplinary teams in order to achieve the effectiveness of nursing care for patients.

摘要

背景

经动脉化疗栓塞术(TACE)后会产生影响患者的副作用,导致疲劳症状和功能状态下降。然而,疲劳未缓解和功能状态降低可能会使患者停止治疗,并对其生活产生负面影响。不幸的是,TACE术后患者在医院仅接受常规医疗护理,回家后却没有后续跟进和持续护理。因此,针对这些问题进行全面的出院计划很有必要。

目的

本研究探讨了全面出院计划方案对接受经动脉化疗栓塞术的肝细胞癌患者疲劳和功能状态的影响。

方法

采用随机临床对照试验。将52例符合研究标准的患者随机分为实验组(n = 26),接受全面出院计划加常规护理;对照组(n = 26),仅接受常规护理。出院计划方案基于过渡护理模式制定。使用人口统计学和健康数据问卷、疲劳严重程度量表(FSS)和强制社会依赖量表(ESDS)进行数据收集。采用卡方检验、Fisher精确检验、Wilcoxon符号秩检验和Mann-Whitney U检验进行数据分析。

结果

实验组和对照组治疗后30天的疲劳平均得分有显著差异(P = 0.003)。实验组和对照组的疲劳症状平均得分分别为1.27±0.58和1.77±0.85。经动脉化疗栓塞术后第7天至第14天的功能状态有所不同(P = 0.020)。此外,实验组和对照组的功能状态平均得分有显著差异(P = 0.020)。经动脉化疗栓塞术后第14天,实验组的功能状态得分相比第7天有所增加,高于对照组。

结论

全面出院计划方案可有效减轻接受经动脉化疗栓塞术的肝细胞癌患者的疲劳症状,并提高其功能状态。因此,护士和多学科团队可采用全面出院计划方案,以实现对患者的护理效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/061c/10401379/b8dc10280106/BNJ-8-4-287-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/061c/10401379/4465d54eef05/BNJ-8-4-287-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/061c/10401379/b8dc10280106/BNJ-8-4-287-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/061c/10401379/4465d54eef05/BNJ-8-4-287-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/061c/10401379/b8dc10280106/BNJ-8-4-287-g002.jpg

相似文献

1
A comprehensive discharge planning program on fatigue and functional status of patients with hepatocellular carcinoma undergoing transarterial chemoembolization: A randomized clinical controlled trial.一项关于经动脉化疗栓塞术治疗的肝细胞癌患者疲劳和功能状态的综合出院计划项目:一项随机临床对照试验。
Belitung Nurs J. 2022 Aug 18;8(4):287-295. doi: 10.33546/bnj.2140. eCollection 2022.
2
Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study.经动脉化疗栓塞术联合仑伐替尼对比经动脉化疗栓塞术联合索拉非尼作为伴门静脉癌栓的肝细胞癌一线治疗的前瞻性随机研究。
Cancer. 2021 Oct 15;127(20):3782-3793. doi: 10.1002/cncr.33677. Epub 2021 Jul 8.
3
Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.经动脉放射性栓塞与化疗栓塞治疗肝细胞癌(TRACE):一项随机对照试验的研究方案。
Trials. 2012 Aug 23;13:144. doi: 10.1186/1745-6215-13-144.
4
Prevalence and Risk Factors of Post-chemoembolization Syndrome After Chemo-Embolization for Hepatocellular Carcinoma in Thailand.泰国肝细胞癌化疗栓塞术后化疗栓塞综合征的患病率及危险因素。
Dig Dis Sci. 2023 Sep;68(9):3818-3823. doi: 10.1007/s10620-023-08010-3. Epub 2023 Jul 4.
5
Cidan Capsule in Combination with Adjuvant Transarterial Chemoembolization Reduces Recurrence Rate after Curative Resection of Hepatocellular Carcinoma: A Multicenter, Randomized Controlled Trial.慈丹胶囊联合肝动脉化疗栓塞术可降低肝细胞癌根治性切除术后的复发率:一项多中心随机对照试验
Chin J Integr Med. 2023 Jan;29(1):3-9. doi: 10.1007/s11655-022-3537-4. Epub 2022 Aug 1.
6
Comparison of health-related quality of life after transarterial chemoembolization and transarterial radioembolization in patients with unresectable hepatocellular carcinoma.比较不可切除肝细胞癌患者经动脉化疗栓塞术和经动脉放射栓塞术治疗后的健康相关生活质量。
Abdom Radiol (NY). 2019 Apr;44(4):1554-1561. doi: 10.1007/s00261-018-1802-y.
7
Effect of camrelizumab plus transarterial chemoembolization on massive hepatocellular carcinoma.卡瑞利珠单抗联合肝动脉化疗栓塞治疗巨块型肝癌的效果。
Clin Res Hepatol Gastroenterol. 2022 Apr;46(4):101851. doi: 10.1016/j.clinre.2021.101851. Epub 2021 Dec 17.
8
[Comparison of doxorubicin-eluting bead transarterial chemoembolization (DEB-TACE) with conventional transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma].多柔比星洗脱微球经动脉化疗栓塞术(DEB-TACE)与传统经动脉化疗栓塞术(TACE)治疗肝细胞癌的比较
Radiologia. 2011 May-Jun;53(3):246-53. doi: 10.1016/j.rx.2010.07.010. Epub 2011 Feb 4.
9
The effects of a transitional care program on discharge readiness, transitional care quality, health services utilization and satisfaction among Chinese kidney transplant recipients: A randomized controlled trial.过渡护理方案对中国肾移植受者出院准备度、过渡护理质量、卫生服务利用和满意度的影响:一项随机对照试验。
Int J Nurs Stud. 2020 Oct;110:103700. doi: 10.1016/j.ijnurstu.2020.103700. Epub 2020 Jun 26.
10
Transarterial Chemoembolization of Hepatocellular Carcinoma with Oncozene Microspheres: An Initial, Short-Term Clinical Experience-A Retrospective, Matched, Comparison Study.用Oncozene微球经动脉化疗栓塞治疗肝细胞癌:初步短期临床经验——一项回顾性配对比较研究
Life (Basel). 2021 Jun 23;11(7):600. doi: 10.3390/life11070600.

引用本文的文献

1
Influence of transcatheter arterial embolization on symptom distress and fatigue in liver cancer patients.经导管动脉栓塞术对肝癌患者症状困扰和疲劳的影响。
World J Gastrointest Oncol. 2024 Mar 15;16(3):810-818. doi: 10.4251/wjgo.v16.i3.810.

本文引用的文献

1
Effects of in-hospital exercise on sarcopenia in hepatoma patients who underwent transcatheter arterial chemoembolization.住院期间运动对经导管动脉化疗栓塞治疗的肝癌患者肌少症的影响。
J Gastroenterol Hepatol. 2019 Mar;34(3):580-588. doi: 10.1111/jgh.14538. Epub 2018 Dec 16.
2
Adaptations of the evidence-based Transitional Care Model in the U.S.美国基于证据的过渡护理模式的改编
Soc Sci Med. 2018 Sep;213:28-36. doi: 10.1016/j.socscimed.2018.07.023. Epub 2018 Jul 17.
3
CanWalk: a feasibility study with embedded randomised controlled trial pilot of a walking intervention for people with recurrent or metastatic cancer.
CanWalk:一项针对复发性或转移性癌症患者步行干预的可行性研究,其中嵌入了随机对照试验试点。
BMJ Open. 2017 Feb 15;7(2):e013719. doi: 10.1136/bmjopen-2016-013719.
4
[Relationship Between Symptom Distress and Fatigue in Hepatocellular Carcinoma Patients Who Received Transcatheter Arterial Embolization].接受经动脉化疗栓塞术的肝细胞癌患者症状困扰与疲劳之间的关系
Hu Li Za Zhi. 2015 Jun;62(3):57-65. doi: 10.6224/JN.62.3.57.
5
Effects of acupressure on fatigue and depression in hepatocellular carcinoma patients treated with transcatheter arterial chemoembolization: a quasi-experimental study.按压穴位对经导管动脉化疗栓塞治疗肝细胞癌患者疲劳和抑郁的影响:一项准实验研究。
Evid Based Complement Alternat Med. 2015;2015:496485. doi: 10.1155/2015/496485. Epub 2015 Feb 23.
6
Transitions of care in heart failure: a scientific statement from the American Heart Association.心力衰竭的照护过渡:美国心脏协会的科学声明
Circ Heart Fail. 2015 Mar;8(2):384-409. doi: 10.1161/HHF.0000000000000006. Epub 2015 Jan 20.
7
Effect of exercise on cancer-related fatigue: a meta-analysis.运动对癌症相关疲劳的影响:一项荟萃分析。
Am J Phys Med Rehabil. 2014 Aug;93(8):675-86. doi: 10.1097/PHM.0000000000000083.
8
A home-based exercise program to improve function, fatigue, and sleep quality in patients with Stage IV lung and colorectal cancer: a randomized controlled trial.一项基于家庭的运动计划改善 IV 期肺癌和结直肠癌患者的功能、疲劳和睡眠质量:一项随机对照试验。
J Pain Symptom Manage. 2013 May;45(5):811-21. doi: 10.1016/j.jpainsymman.2012.05.006. Epub 2012 Sep 24.
9
Symptom clusters and symptom interference of HCC patients undergoing TACE: a cross-sectional study in China.接受 TACE 治疗的 HCC 患者的症状群及症状干扰:中国的一项横断面研究。
Support Care Cancer. 2013 Feb;21(2):475-83. doi: 10.1007/s00520-012-1541-5. Epub 2012 Jul 20.
10
Quality of life and its associated factors in patients with hepatocellular carcinoma receiving one course of transarterial chemoembolization treatment: a longitudinal study.肝癌患者接受一次经动脉化疗栓塞治疗后的生活质量及其相关因素:一项纵向研究。
Oncologist. 2012;17(5):732-9. doi: 10.1634/theoncologist.2011-0368. Epub 2012 Apr 17.